Table 1.
N (%) | |
---|---|
| |
Total number of patients | 266 |
| |
Median age (range) | 43 years (15–94) |
| |
Stage | |
I | 181 (68) |
II | 18 (6.8) |
III/IV | 67 (25.2) |
| |
Histology | |
Serous | 196 (73.7) |
Mucinous | 64 (24.1) |
Clear cell | 3 (1.1) |
Endometrioid | 3 (1.1) |
| |
Lymphadenectomy | |
Yes | 128 (48.1) |
No | 138 (51.9) |
Median lymph nodes sampled (range) | 14.5 (1–45) |
| |
Adjuvant chemotherapy | |
Yes | 20 (7.5) |
No | 249 (92.5) |
| |
Median follow-up (range) | 3.7 years (0–22.8) |
| |
Status at last follow-up* | |
NED | 224 (84.2) |
AWD | 15 (5.6) |
DOD | 7 (2.6) |
DOO | 17 (6) |
Lost to follow-up | 3 (1.1) |
| |
Recurrence | |
Yes | 23 (8.6) |
No | 243 (91.4) |
NED = no evidence of disease, AWD = alive with disease, DOD = dead of disease, DOO = dead of other causes